GlassScriptPhysician profile
Kyle Glasser
NPI 1255894119
$1,015.52
in general payments reported to CMS, 2019-2025
15 companies · $782 in 2025
The $782 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $23.34 · 2024: $210 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $215.07 | 2024-2025 | Wavewriter Alpha Prime 16, Clinical Trial Product |
| Globus Medical, INC. | $139.37 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $116.17 | 2024-2025 | Xtampza |
| Spinal Simplicity, LLC | $93.33 | 2025 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.56 | 2025 | Relistor |
| Forte Bio-Pharma LLC | $69.02 | 2025 | Prolate, Nalocet, Tanlor |
| Averitas Pharma INC. | $64.69 | 2024-2025 | Qutenza |
| Novo Nordisk INC | $55.99 | 2024 | Wegovy |
| Scilex Pharmaceuticals INC. | $42.57 | 2025 | |
| Saluda Medical Americas, INC. | $31.02 | 2024-2025 | Evoke |
| Alexion Pharmaceuticals, INC. | $27.98 | 2025 | Ultomiris |
| Medtronic, INC. | $23.34 | 2023 | Kyphon Express II Kyphopak Tray |
| Si-Bone, INC. | $18.42 | 2025 | |
| Azurity Pharmaceuticals, INC. | $15.17 | 2024 | Horizant |
| Mml US, INC. | $10.82 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Glasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.